000 01378 a2200409 4500
005 20250515131229.0
264 0 _c20080820
008 200808s 0 0 eng d
022 _a1532-1827
024 7 _a10.1038/sj.bjc.6604525
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aGüth, U
245 0 0 _aTarget and reality of adjuvant endocrine therapy in postmenopausal patients with invasive breast cancer.
_h[electronic resource]
260 _bBritish journal of cancer
_cAug 2008
300 _a428-33 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAged
650 0 4 _aAntineoplastic Agents, Hormonal
_xtherapeutic use
650 0 4 _aBreast Neoplasms
_xdrug therapy
650 0 4 _aChemotherapy, Adjuvant
650 0 4 _aHumans
650 0 4 _aMiddle Aged
650 0 4 _aNeoplasm Invasiveness
650 0 4 _aPatient Compliance
650 0 4 _aPostmenopause
650 0 4 _aReceptors, Estrogen
_xmetabolism
650 0 4 _aReceptors, Progesterone
_xmetabolism
650 0 4 _aTamoxifen
_xtherapeutic use
700 1 _aHuang, D J
700 1 _aSchötzau, A
700 1 _aZanetti-Dällenbach, R
700 1 _aHolzgreve, W
700 1 _aBitzer, J
700 1 _aWight, E
773 0 _tBritish journal of cancer
_gvol. 99
_gno. 3
_gp. 428-33
856 4 0 _uhttps://doi.org/10.1038/sj.bjc.6604525
_zAvailable from publisher's website
999 _c18141897
_d18141897